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Comparison of four common heat and moisture 
exchangers used in the laryngectomized patient
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P. F.  S C H O U W H N B U R G  & R . C .  H A M A K E R
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rdam .
study on a new strategy combining accelerated radi 
with carbogen and nicotinamide.
Patients with laryngeal (stage li l  IV) and hypopharyngeal 
(stage II IV) tumours and patients with unresec table tumours 
of the oral cavity and oropharynx received primary radio­
therapy. Scuba-diving equipment was for carbogen
Laryngectomy results in a bypassed upper airway and places 
the burden o f  humidification on the lower airway. For this 
reason passive heat and moisture exchangers (HMEs) are used 
in the laryngectomized patient in an attempt to minimize the 
effect of  lost upper airway function. The question however is: 
‘do these filters meet up with the desired efficiency?’ To answer 
this question, we measured the moisture efiiciency and airflow 
resistance o f  four common HM Es used in the laryngectomized 
patient.
The H M Es were measured according to a modified ISO 
9360 standard. The airflow resistance was measured at flow 
rates of 15,30 and 60 L/min. The measurements were repeated 
three times.
There were significant differences in moisture output and 
airflow resistance between the HMEs tested. The results were 
highly reproducible.
delivery. Nicotinamide was administered orally 1 h before 
irradiation. The overall treatment time was reduced by 8 10 
days by giving two fractions per day during the last part of 
the treatment.
One hundred and patients have included.
Mucosal reactions were increased but healing was complete 
in all patients. Frequent side-effects of nicotinamide are nau­
sea and vomiting. One year actuarial locoregional control was 
84% for patients with larynx and hypopharyngeal tumours 
and 37% for patients with far advanced oral cavity and oro­
pharyngeal tumours.
This new treatment is feasible and s are
acceptable. Preliminary tumour control rates are very encour­
aging.
Filter material and size Ì the H MB’s moisture out- Genetic susceptibility to head and neck s
put efficiency and airflow resistance. The differences run as cell carcinoma. A multicenter case-coiltrol Study
high as approximately 20%. The construction differences, fil­
ter and housing type, have considerable influence on the daily 
HMEs costs. We believe that knowledge of the efficiency in 
combination with the average daily costs of  the HM Es allows 
the clinician to make a balanced choice of which filter to use. 
None of the HM Es is as efficient as the nose.
J .  C L O O S ,  B . J . M .  B R A A K H U I S ,  M. R.  S P I T Z ,  S . P.  S C I I A N T Z
& G . » .  S N O W Í Amsterdam, Houston, New York)
In  i o n  to snces of exposure to carcinogenic com­
pounds, the development of cancer may also depend on an 
individual intrinsic cancer susceptibility. Biomarkers lor can-
can be a powerful addition to epi- 
ical analyses. Mutagen sensitivity (mean number of
Accelerated radiotherapy with carbogen breathing 
and nicotinamide in head and neck cancer
J . H . A . M .  K A A NI > I; R S , L . A . M .  POP &
u . a . m . M A R R RS ( N ijlliegen  )
Factors which adversely influence the radiation response of  
tumours are cellular repopulation and tumour hypoxia. 
Chronic hypoxia results from a low p 0 2 in tissues which
increased by carbogen (95% 0 2 +  5% C 0 2) breathing. 
Acute hypoxia is caused by fluctuations in tumour blood 
perfusion and can be reduced by nicotinamide. Accelerated 
radiotherapy can counteract tumour repopulation. This is a
chromatid breaks per cell of cultured lym ;s t ret
with ; in  in late S-G2 phase of ceil c » 1  £*
determined in 313 patients with head and neck cancer and 334 
controls. There were no differences across the three insti­
tutions involved in the distribution o f  mutagen sensitivity for 
both subjects and controls. Values for patients were con­
sistently and significantly (P <  0.0001 ) higher compared to 
values for controls in the overall analyses. Age, tobacco, or 
alcohol use, did not influence the outcome in terms of mutagen 
sensitivity values for either the patients or controls. A mean 
number o f  breaks per cell dichotomized at 1.0, was found to 
be the best predictor of a hypersensitive phenotype. For non­
sensitive heavy smokers the odds ratio (OR) is 11.5. The OR
178 ci 1997 Blackwell Science Ltd
